International Recognition Procedure

From 1 January 2024, the EC Decision Reliance Procedure (ECDRP) has been replaced by the new International Recognition procedure (IRP). The Mutual Recognition/Decentralized Reliance Procedure (MRDCRP) has been incorporated under the umbrella of IRP.

IRP will allow the MHRA to take into account the expertise and decision-making of trusted regulatory partners for the benefit of UK patients. The MHRA will conduct a targeted assessment of IRP applications but retain the authority to reject applications if the evidence provided is considered insufficiently robust.

Who Should Watch:
• Pharmaceutical professionals
• Regulatory affairs specialists

Don't forget to like, comment, and subscribe for more insights into pharmaceutical industry best practices and translation services. Hit the bell icon to stay updated with our latest videos!

Follow Us:
• Our website: https://www.neocubespharma.com/
https://www.neoplustranslation.com/
• Linked in: https://www.linkedin.com/company/neoplustr...
• Instagram: https://www.instagram.com/neocubes__pharma/

Thank you for watching!